VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 101 filers reported holding VERVE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,055,509 | -29.1% | 79,602 | +0.3% | 0.00% | -50.0% |
Q2 2023 | $1,488,431 | +143709.8% | 79,383 | +10.6% | 0.00% | +100.0% |
Q1 2023 | $1,035 | -21.3% | 71,794 | +5.7% | 0.00% | -50.0% |
Q4 2022 | $1,315 | -99.9% | 67,933 | +6.0% | 0.00% | -33.3% |
Q3 2022 | $2,201,000 | +183.6% | 64,067 | +26.2% | 0.00% | +200.0% |
Q2 2022 | $776,000 | -8.1% | 50,763 | +37.3% | 0.00% | 0.0% |
Q1 2022 | $844,000 | +28.5% | 36,980 | +107.5% | 0.00% | 0.0% |
Q4 2021 | $657,000 | -20.7% | 17,824 | +1.0% | 0.00% | 0.0% |
Q3 2021 | $829,000 | – | 17,640 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alphabet Inc. | 10,974,011 | $167,683,000 | 9.10% |
ARCH Venture Management, LLC | 2,508,809 | $38,335,000 | 4.67% |
Casdin Capital, LLC | 3,138,167 | $47,951,000 | 4.05% |
M28 Capital Management LP | 178,500 | $2,727,000 | 3.06% |
Redmile Group, LLC | 1,833,547 | $28,017,000 | 1.07% |
Cormorant Asset Management, LP | 700,710 | $10,707,000 | 0.81% |
Novo Holdings A/S | 927,100 | $14,166,000 | 0.70% |
Pinz Capital Management, LP | 51,800 | $792,000 | 0.54% |
PFM Health Sciences, LP | 845,186 | $12,914,000 | 0.49% |
Artal Group S.A. | 400,000 | $6,112,000 | 0.33% |